$2.95 Billion is the total value of BRADLEY FOSTER & SARGENT INC/CT's 367 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLL | New | Ball Corp | $22,662,000 | – | 515,165 | +100.0% | 0.77% | – |
| ARMK | New | Aramark | $7,106,000 | – | 165,175 | +100.0% | 0.24% | – |
| DOCU | New | DocuSign Inc | $1,627,000 | – | 30,940 | +100.0% | 0.06% | – |
| FDC | New | First Data Corp | $1,305,000 | – | 53,344 | +100.0% | 0.04% | – |
| KDP | New | Keurig Dr Pepper Inc | $1,127,000 | – | 48,647 | +100.0% | 0.04% | – |
| RP | New | RealPage Inc. | $1,080,000 | – | 16,395 | +100.0% | 0.04% | – |
| CDAY | New | Ceridian HCM Holding Inc | $851,000 | – | 20,239 | +100.0% | 0.03% | – |
| OKTA | New | Okta Inc | $706,000 | – | 10,040 | +100.0% | 0.02% | – |
| CRSP | New | CRISPR Therapeutics AG | $420,000 | – | 9,460 | +100.0% | 0.01% | – |
| LLL | New | L3 Technologies Inc. | $307,000 | – | 1,444 | +100.0% | 0.01% | – |
| IMMU | New | Immunomedics, Inc | $297,000 | – | 14,250 | +100.0% | 0.01% | – |
| TDOC | New | Teladoc Inc | $263,000 | – | 3,050 | +100.0% | 0.01% | – |
| GSK | New | GlaxoSmithKline PLC | $259,000 | – | 6,455 | +100.0% | 0.01% | – |
| CDEV | New | Centennial Resource Developmen | $262,000 | – | 11,985 | +100.0% | 0.01% | – |
| BP | New | BP PLC | $224,000 | – | 4,855 | +100.0% | 0.01% | – |
| COP | New | Conoco Phillips | $249,000 | – | 3,218 | +100.0% | 0.01% | – |
| ALK | New | Alaska Air | $232,000 | – | 3,375 | +100.0% | 0.01% | – |
| WST | New | West Pharmaceutical Services I | $210,000 | – | 1,700 | +100.0% | 0.01% | – |
| XLV | New | Select Sector S&P Health Care | $202,000 | – | 2,123 | +100.0% | 0.01% | – |
| UPS | New | United Parcel Service Class B | $204,000 | – | 1,749 | +100.0% | 0.01% | – |
| IJR | New | iShares Core S&P 600 Small Cap | $200,000 | – | 2,298 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-10-31
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft | 41 | Q3 2023 | 5.6% |
| Apple Inc | 41 | Q3 2023 | 5.0% |
| J P Morgan Chase | 41 | Q3 2023 | 3.7% |
| Danaher | 41 | Q3 2023 | 3.7% |
| Pepsico | 41 | Q3 2023 | 2.4% |
| Johnson & Johnson | 41 | Q3 2023 | 2.3% |
| Thermo Fisher Scientific | 41 | Q3 2023 | 2.8% |
| Walt Disney | 41 | Q3 2023 | 2.5% |
| Marsh & McLennan | 41 | Q3 2023 | 2.0% |
| Merck | 41 | Q3 2023 | 2.0% |
View BRADLEY FOSTER & SARGENT INC/CT's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| METROLOGIC INSTRUMENTS INC | February 11, 2000 | 293,562 | 5.4% |
View BRADLEY FOSTER & SARGENT INC/CT's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-03-11 |
View BRADLEY FOSTER & SARGENT INC/CT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.